The Cardiac Effects Of Hydroxychloroquine In Immune-mediated Rheumatologic Diseases

Authors

Emily Weidman-Evans, LSU Health Sciences Center - New OrleansFollow
Mandy Porter, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

4-1-2022

Publication Title

Journal of the American Academy of Physician Assistants

Abstract

Hydroxychloroquine, when used to treat patients with rheumatoid arthritis or systemic lupus erythematosus, has been found to reduce cardiovascular disease (CVD). The drug also has been associated with cardiac adverse reactions such as conduction abnormalities. This article reviews the reduction of CVD and the cardiac adverse reactions associated with hydroxychloroquine.

First Page

51

Last Page

53

PubMed ID

35348541

Volume

35

Issue

4

Recommended Citation

Weidman-Evans, Emily and Porter, Mandy, "The Cardiac Effects Of Hydroxychloroquine In Immune-mediated Rheumatologic Diseases" (2022). School of Allied Health Professions Faculty Publications. 19.
https://digitalscholar.lsuhsc.edu/soah_facpubs/19
10.1097/01.JAA.0000805852.13262.54